Marcus Evans Group | Worldwide Headquarters | American Offices | Latin America | European Offices | African / Asian Offices

Nurofen tampering charge: accused remanded in custody

Christopher McGuire charged with contaminating Nurofen Plus painkillers with anti-psychotic drugs

A man has been remanded in custody accused of contaminating packs of Nurofen Plus painkillers with anti-psychotic and anti-epileptic drugs.

Christopher McGuire, 30, of no fixed address, appeared in a brief hearing at west London magistrates court. He spoke only to confirm his name and date of birth.

McGuire is charged with four counts of contamination of goods, and two counts of administering a noxious substance. The maximum sentence if convicted is 10 years in jail.

He was remanded by District Judge John Zani to appear at Southwark crown court on 2 December for a plea and case management hearing.

Reckitt Benckiser, manufacturer of the drug, recalled the product on 26 August and halted distribution after discovering five boxes contained other companies’ medicines. It estimated that some 250,000 packets were still in customers’ hands.

Four of the boxes were found to contain the anti-psychotic drug Seroquel XL 50mg and one packet contained Pfizer’s anti-epileptic medication Neurontin, in 100mg capsules.

The charges against McGuire state that between 1 June and 26 August this year he contaminated packets of Nurofen Plus at three branches of Boots the chemist, in London’s Victoria railway station, in Beckenham High Street, south-east London and in the Glades, Bromley, south-east London, and at Beckenham Independent Pharmacy in Beckenham.

He is accused of administering a noxious substance, Seroquel, to two people on 22 August this year. © 2011 Guardian News and Media Limited or its affiliated companies. All rights reserved. | Use of this content is subject to our Terms & Conditions | More Feeds